← Open Payments lookup

ROY ALLAN ELEVAZO: Open Payments

NPI 1427489483 · LAKEWOOD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,705 in 87 payments from 10 companies in 2025. Trend: 2023 $2,645 · 2024 $1,482 · 2025 $1,705

Food & beverage: $1,705
CompanyPaymentsAmount
ABBVIE INC.20$399
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)20$388
Otsuka America Pharmaceutical, Inc.14$243
Vanda Pharmaceuticals Inc.9$174
Axsome Therapeutics, Inc.6$155
Noven Therapeutics, LLC9$145
Lundbeck LLC3$85
Alkermes, Inc.3$60
Takeda Pharmaceuticals U.S.A., Inc.2$36
Neos Therapeutics, LP1$21

Products named: VRAYLAR, CAPLYTA, REXULTI, FANAPT, Auvelity, Xelstrym, ARISTADA, TRINTELLIX.

Industry payments across CA — which companies pay providers there.